Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Strong Xtandi Drives Astellas To Brighter Outlook

Nov 05 2018

• By Ian Haydock

currency — Strong US Xtandi Performance Boosts Astellas • Source: Shutterstock

Additional Topics

Japan Asia Pacific United States Commercial Business Strategies Regenerative Medicine Cancer BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.